← Leaderboards
Hermine I Brunner
Children'S Hospital Med Ctr (Cincinnati)
$8,150,642
Attributed
$11,311,292
Total exposure
23
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,529,570 · 23
FDA$191,267 · 1
By mechanism
R01$5,156,534 · 3
P30$4,423,345 · 3
U01$2,978,127 · 5
P60$1,236,348 · 1
R34$419,760 · 1
UH2$250,000 · 1
Top collaborators
- Michael R. Bennett4 shared
- Prasad Devarajan4 shared
- Alexander A. Vinks3 shared
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Susmita Kashikar-Zuck$15,689,768
- Susan D Thompson$11,267,165
- David N. Glass$5,716,834
- Alexander A. Vinks$6,037,579
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildChildhoodAdultUnited States National Institutes Of HealthFundingResearch PersonnelPharmaceutical PreparationsSystemic Lupus ErythematosusInnovationLupusBaseRheumatologyResponseClinical ResearchMethodologyClinical TrialsProgramsQuality Of LifeBiological MarkersConsensusEnrollmentNational Institute Of Arthritis And Musculoskeletal And Skin DiseasesFlareOrgan
Grant awards (54)
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study$1,167,839
R01 · FY2025 · AR · contact PI
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study$1,149,669
R01 · FY2024 · AR · contact PI
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study$1,196,009
R01 · FY2023 · AR · contact PI
Pediatric musculOskeletal & RheumaTology Innovation COre center (PORTICO)$659,902
P30 · FY2023 · AR · contact PI
Administrative Core$190,866
P30 · FY2023 · AR · contact PI
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study$1,255,070
R01 · FY2022 · AR · contact PI
Pediatric musculOskeletal & RheumaTology Innovation COre center (PORTICO)$678,779
P30 · FY2022 · AR · contact PI
Administrative Core$204,859
P30 · FY2022 · AR · contact PI
Pediatric musculOskeletal & RheumaTology Innovation COre center (PORTICO)$683,883
P30 · FY2021 · AR · contact PI
Administrative Core$204,859
P30 · FY2021 · AR · contact PI
Pediatric musculOskeletal & RheumaTology Innovation COre center (PORTICO)$692,717
P30 · FY2020 · AR · contact PI
Administrative Core$208,287
P30 · FY2020 · AR · contact PI
Pediatric musculOskeletal & RheumaTology Innovation COre center (PORTICO)$694,264
P30 · FY2019 · AR · contact PI
Administrative Core$204,929
P30 · FY2019 · AR · contact PI
Improving Pediatric Lupus Nephritis Through Personalized Mycophenolate Mofetil Therapy$174,900
R34 · FY2019 · AR · contact PI
Improving Pediatric Lupus Nephritis Through Personalized Mycophenolate Mofetil Therapy$244,860
R34 · FY2018 · AR · contact PI
Optimization of Outcome Measures For Clinical Trials in Children with Lupus$196,023
U01 · FY2016 · AR · contact PI
Innovative Efficacy Measures of Lupus Nephritis Therapies$196,087
U01 · FY2015 · AR · contact PI
Optimization of Outcome Measures For Clinical Trials in Children with Lupus$195,464
U01 · FY2015 · AR · contact PI
Cincinnati Center for Innovative Medicine in Adult & Pediatric Rheumatology$250,000
UH2 · FY2014 · AR · contact PI
Optimization of Outcome Measures For Clinical Trials in Children with Lupus$220,462
U01 · FY2014 · AR · contact PI
Innovative Efficacy Measures of Lupus Nephritis Therapies$197,694
U01 · FY2014 · AR · contact PI
Innovative Efficacy Measures of Lupus Nephritis Therapies$99,959
U01 · FY2014 · AR · contact PI
Innovative Efficacy Measures of Lupus Nephritis Therapies$220,857
U01 · FY2013 · AR · contact PI
Improved Diagnostics & Advanced Magnetic Resonance Imaging for Pediatric NPSLE$246,583
P60 · FY2012 · AR · contact PI
Towards Measures of Lupus Nephritis Activity & Damage for Children$187,156
U01 · FY2012 · AR · contact PI
Improved Diagnostics & Advanced Magnetic Resonance Imaging for Pediatric NPSLE$245,280
P60 · FY2011 · AR · contact PI
Towards Measures of Lupus Nephritis Activity & Damage for Children$198,470
U01 · FY2011 · AR · contact PI
Towards Measures of Lupus Nephritis Activity & Damage for Children$206,553
U01 · FY2010 · AR · contact PI
Improved Diagnostics & Advanced Magnetic Resonance Imaging for Pediatric NPSLE$186,581
P60 · FY2010 · AR · contact PI
Improved Diagnostics & Advanced Magnetic Resonance Imaging for Pediatric NPSLE$292,406
P60 · FY2009 · AR · contact PI
Efficacy Measures for Pediatric Lupus Studies$190,590
U01 · FY2009 · AR · contact PI
Efficacy Measures for Pediatric Lupus Studies$131,716
U01 · FY2009 · AR · contact PI
Improved Diagnostics & Advanced Magnetic Resonance Imaging for Pediatric NPSLE$265,498
P60 · FY2008 · AR · contact PI
Efficacy Measures for Pediatric Lupus Studies$193,224
U01 · FY2008 · AR · contact PI
CLINICAL TRIAL: TRIPTORELIN FOR OVARY PROTECTION IN LUPUS$2,601
M01 · FY2008 · RR · contact PI
Efficacy Measures for Pediatric Lupus Studies$201,180
U01 · FY2007 · AR · contact PI
TRIPTORELIN FOR OVARY PROTECTION IN CHILDHOOD LIPUS$191,267
R01 · FY2007 · FD · contact PI
LONG-TERM OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS$13,371
M01 · FY2007 · RR · contact PI
ATHEROSCLEROSIS PREVENTION IN PEDIATRIC LUPUS ERYTHEMATOSUS (APPLE)$2,228
M01 · FY2007 · RR · contact PI
TRIPTORELIN FOR OVARY PROTECTION IN LUPUS$1,671
M01 · FY2007 · RR · contact PI
Meaningful Outcome Measures for Pediatrc Lupus Trials$165,249
U01 · FY2006 · AR · contact PI
LONG-TERM OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS$5,316
M01 · FY2006 · RR · contact PI
TRIPTORELIN FOR OVARY PROTECTION IN LUPUS$2,954
M01 · FY2006 · RR · contact PI
ATHEROSCLEROSIS PREVENTION IN PEDIATRIC LUPUS ERYTHEMATOSUS (APPLE)$1,772
M01 · FY2006 · RR · contact PI
Meaningful Outcome Measures for Pediatrc Lupus Trials$177,443
U01 · FY2005 · AR
Guidelines for Steroids in Children with Lupus$74,000
R03 · FY2005 · AR
LONG-TERM OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS$1,844
M01 · FY2005 · RR
TRIPTORELIN FOR OVARY PROTECTION IN LUPUS$1,383
M01 · FY2005 · RR
TRIPTORELIN FOR OVARY PROTECTION IN CHILDHOOD LIPUS$0
R01 · FY2005 · FD
Meaningful Outcome Measures for Pediatric Lupus Trials$196,680
R01 · FY2004 · AR
Guidelines for Steroids in Children with Lupus$74,000
R03 · FY2004 · AR
Gonadal Function in Childhood Onset SLE$1,583
M01 · FY2004 · RR
Guidelines for Steroids in Children with Lupus$74,000
R03 · FY2003 · AR